Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Bjerner

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical Chemistry|February 19, 2005
Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodiesDavid J Warren, Johan Bjerner, Elisabeth Paus, et al.
Clinical Chemistry|April 30, 2008
Automated time-resolved immunofluorometric assay for progastrin-releasing peptideMarianne S Nordlund, David J Warren, Kjell Nustad, et al.
Clinical Chemistry|March 20, 2002
Immunometric assay interference: incidence and preventionJohan Bjerner, Kjell Nustad, Lars F Norum, et al.
Annals of Clinical Biochemistry|December 15, 2025
Estimation of half-life with confidence interval for phosphatidylethanol (PEth) in blood based on two consecutive measurementsJohan Bjerner, Michael Sovershaev, Elisabeth Wiik Vigerust, et al.
Plos One|July 6, 2021
Rapid diagnosis and reduced workload for urinary tract infection using flowcytometry combined with direct antibiotic susceptibility testingHanne Margrethe Gilboe, Olaug Marie Reiakvam, Linda Aasen, et al.
BJU International|October 23, 2023
Opportunistic prostate-specific antigen testing in Norwegian men: a public health challengePeter C Albertsen, Lars Johan Bjerner, Lara Pasovic, et al.
Clinical Biochemistry|December 5, 2017
Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumorsRagnhild V Nome, Trine Bjøro, Elisabeth Paus, et al.
Clinical Chemistry and Laboratory Medicine|September 9, 2011
Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked seraNils Bolstad, David J Warren, Johan Bjerner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivorsMette Sprauten, Marianne Brydøy, Hege S Haugnes, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 9, 2008
Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP studyJohan Bjerner, Anita Høgetveit, Katrine Wold Akselberg, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical Chemistry|February 19, 2005
Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodiesDavid J Warren, Johan Bjerner, Elisabeth Paus, et al.
Clinical Chemistry|April 30, 2008
Automated time-resolved immunofluorometric assay for progastrin-releasing peptideMarianne S Nordlund, David J Warren, Kjell Nustad, et al.
Clinical Chemistry|March 20, 2002
Immunometric assay interference: incidence and preventionJohan Bjerner, Kjell Nustad, Lars F Norum, et al.
Annals of Clinical Biochemistry|December 15, 2025
Estimation of half-life with confidence interval for phosphatidylethanol (PEth) in blood based on two consecutive measurementsJohan Bjerner, Michael Sovershaev, Elisabeth Wiik Vigerust, et al.
Plos One|July 6, 2021
Rapid diagnosis and reduced workload for urinary tract infection using flowcytometry combined with direct antibiotic susceptibility testingHanne Margrethe Gilboe, Olaug Marie Reiakvam, Linda Aasen, et al.
BJU International|October 23, 2023
Opportunistic prostate-specific antigen testing in Norwegian men: a public health challengePeter C Albertsen, Lars Johan Bjerner, Lara Pasovic, et al.
Clinical Biochemistry|December 5, 2017
Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumorsRagnhild V Nome, Trine Bjøro, Elisabeth Paus, et al.
Clinical Chemistry and Laboratory Medicine|September 9, 2011
Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked seraNils Bolstad, David J Warren, Johan Bjerner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivorsMette Sprauten, Marianne Brydøy, Hege S Haugnes, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 9, 2008
Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP studyJohan Bjerner, Anita Høgetveit, Katrine Wold Akselberg, et al.
Pageof 3